Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions

Samy Selim, Manjula Sunkara, Abdelghaffar K. Salous, Steve W. Leung, Evgeny V. Berdyshev, Alison Bailey, Charles Campbell, Richard Charnigo, Andrew J. Morris, Susan S. Smyth

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Anaemia and RBC (red blood cell) transfusion may be associated with worse clinical outcomes, especially with longer blood storage duration prior to transfusion. The mechanisms underlying these harmful effects are unknown. RBCs have been proposed to buffer plasma S1P (sphingosine 1-phosphate), a lysophospholipid essential for the maintenance of endothelial integrity and important in the regulation of haematopoietic cell trafficking. The present study examined the effect of anaemia, RBC transfusion and RBC storage duration on plasma S1P levels. Plasma S1P from 30 individuals demonstrated a linear correlation with Hct (haematocrit; R2 =0.51, P<0.001) with no evidence for a plateau at Hct values as low as 19%. RBC transfusion in 23 anaemic patients with baseline mean Hct of 22.2+- 0.34% (value is the mean+- S.D.) increased Hct to 28.3+- 0.6% at 72 h. Despite an Hct increase, RBC transfusion failed to elevate plasma S1P consistently. A trend towards an inverse correlation was observed between RBC storage duration and the post-transfusion increase in plasma S1P. After 30 days of storage, RBC S1P decreased to 19% of that observed in fresh (3-7-day-old) RBC segments. RBC membranes contain low levels of both S1P phosphatase and S1P lyase activities that may account for the decline in S1P levels with storage. Our results support a role for RBCs in buffering plasma S1P and identify a disturbance in the capacity after transfusion. Changes in S1P content may contribute to an RBC storage lesion. Further studies should investigate the clinical significance of alterations in circulating S1P levels and the potential value of enriching stored RBCs with S1P.

Original languageEnglish (US)
Pages (from-to)565-572
Number of pages8
JournalClinical science
Volume121
Issue number12
DOIs
StatePublished - Dec 1 2011

Fingerprint

Erythrocyte Transfusion
Hematocrit
Erythrocytes
Anemia
sphingosine 1-phosphate
Lysophospholipids
Buffers
Maintenance
Cell Membrane

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Selim, S., Sunkara, M., Salous, A. K., Leung, S. W., Berdyshev, E. V., Bailey, A., ... Smyth, S. S. (2011). Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions. Clinical science, 121(12), 565-572. https://doi.org/10.1042/CS20110236

Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions. / Selim, Samy; Sunkara, Manjula; Salous, Abdelghaffar K.; Leung, Steve W.; Berdyshev, Evgeny V.; Bailey, Alison; Campbell, Charles; Charnigo, Richard; Morris, Andrew J.; Smyth, Susan S.

In: Clinical science, Vol. 121, No. 12, 01.12.2011, p. 565-572.

Research output: Contribution to journalArticle

Selim, S, Sunkara, M, Salous, AK, Leung, SW, Berdyshev, EV, Bailey, A, Campbell, C, Charnigo, R, Morris, AJ & Smyth, SS 2011, 'Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions', Clinical science, vol. 121, no. 12, pp. 565-572. https://doi.org/10.1042/CS20110236
Selim, Samy ; Sunkara, Manjula ; Salous, Abdelghaffar K. ; Leung, Steve W. ; Berdyshev, Evgeny V. ; Bailey, Alison ; Campbell, Charles ; Charnigo, Richard ; Morris, Andrew J. ; Smyth, Susan S. / Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions. In: Clinical science. 2011 ; Vol. 121, No. 12. pp. 565-572.
@article{12d12e59171140779979d5e222af8f16,
title = "Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions",
abstract = "Anaemia and RBC (red blood cell) transfusion may be associated with worse clinical outcomes, especially with longer blood storage duration prior to transfusion. The mechanisms underlying these harmful effects are unknown. RBCs have been proposed to buffer plasma S1P (sphingosine 1-phosphate), a lysophospholipid essential for the maintenance of endothelial integrity and important in the regulation of haematopoietic cell trafficking. The present study examined the effect of anaemia, RBC transfusion and RBC storage duration on plasma S1P levels. Plasma S1P from 30 individuals demonstrated a linear correlation with Hct (haematocrit; R2 =0.51, P<0.001) with no evidence for a plateau at Hct values as low as 19{\%}. RBC transfusion in 23 anaemic patients with baseline mean Hct of 22.2+- 0.34{\%} (value is the mean+- S.D.) increased Hct to 28.3+- 0.6{\%} at 72 h. Despite an Hct increase, RBC transfusion failed to elevate plasma S1P consistently. A trend towards an inverse correlation was observed between RBC storage duration and the post-transfusion increase in plasma S1P. After 30 days of storage, RBC S1P decreased to 19{\%} of that observed in fresh (3-7-day-old) RBC segments. RBC membranes contain low levels of both S1P phosphatase and S1P lyase activities that may account for the decline in S1P levels with storage. Our results support a role for RBCs in buffering plasma S1P and identify a disturbance in the capacity after transfusion. Changes in S1P content may contribute to an RBC storage lesion. Further studies should investigate the clinical significance of alterations in circulating S1P levels and the potential value of enriching stored RBCs with S1P.",
author = "Samy Selim and Manjula Sunkara and Salous, {Abdelghaffar K.} and Leung, {Steve W.} and Berdyshev, {Evgeny V.} and Alison Bailey and Charles Campbell and Richard Charnigo and Morris, {Andrew J.} and Smyth, {Susan S.}",
year = "2011",
month = "12",
day = "1",
doi = "10.1042/CS20110236",
language = "English (US)",
volume = "121",
pages = "565--572",
journal = "Clinical Science",
issn = "0143-5221",
publisher = "Portland Press Ltd.",
number = "12",

}

TY - JOUR

T1 - Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions

AU - Selim, Samy

AU - Sunkara, Manjula

AU - Salous, Abdelghaffar K.

AU - Leung, Steve W.

AU - Berdyshev, Evgeny V.

AU - Bailey, Alison

AU - Campbell, Charles

AU - Charnigo, Richard

AU - Morris, Andrew J.

AU - Smyth, Susan S.

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Anaemia and RBC (red blood cell) transfusion may be associated with worse clinical outcomes, especially with longer blood storage duration prior to transfusion. The mechanisms underlying these harmful effects are unknown. RBCs have been proposed to buffer plasma S1P (sphingosine 1-phosphate), a lysophospholipid essential for the maintenance of endothelial integrity and important in the regulation of haematopoietic cell trafficking. The present study examined the effect of anaemia, RBC transfusion and RBC storage duration on plasma S1P levels. Plasma S1P from 30 individuals demonstrated a linear correlation with Hct (haematocrit; R2 =0.51, P<0.001) with no evidence for a plateau at Hct values as low as 19%. RBC transfusion in 23 anaemic patients with baseline mean Hct of 22.2+- 0.34% (value is the mean+- S.D.) increased Hct to 28.3+- 0.6% at 72 h. Despite an Hct increase, RBC transfusion failed to elevate plasma S1P consistently. A trend towards an inverse correlation was observed between RBC storage duration and the post-transfusion increase in plasma S1P. After 30 days of storage, RBC S1P decreased to 19% of that observed in fresh (3-7-day-old) RBC segments. RBC membranes contain low levels of both S1P phosphatase and S1P lyase activities that may account for the decline in S1P levels with storage. Our results support a role for RBCs in buffering plasma S1P and identify a disturbance in the capacity after transfusion. Changes in S1P content may contribute to an RBC storage lesion. Further studies should investigate the clinical significance of alterations in circulating S1P levels and the potential value of enriching stored RBCs with S1P.

AB - Anaemia and RBC (red blood cell) transfusion may be associated with worse clinical outcomes, especially with longer blood storage duration prior to transfusion. The mechanisms underlying these harmful effects are unknown. RBCs have been proposed to buffer plasma S1P (sphingosine 1-phosphate), a lysophospholipid essential for the maintenance of endothelial integrity and important in the regulation of haematopoietic cell trafficking. The present study examined the effect of anaemia, RBC transfusion and RBC storage duration on plasma S1P levels. Plasma S1P from 30 individuals demonstrated a linear correlation with Hct (haematocrit; R2 =0.51, P<0.001) with no evidence for a plateau at Hct values as low as 19%. RBC transfusion in 23 anaemic patients with baseline mean Hct of 22.2+- 0.34% (value is the mean+- S.D.) increased Hct to 28.3+- 0.6% at 72 h. Despite an Hct increase, RBC transfusion failed to elevate plasma S1P consistently. A trend towards an inverse correlation was observed between RBC storage duration and the post-transfusion increase in plasma S1P. After 30 days of storage, RBC S1P decreased to 19% of that observed in fresh (3-7-day-old) RBC segments. RBC membranes contain low levels of both S1P phosphatase and S1P lyase activities that may account for the decline in S1P levels with storage. Our results support a role for RBCs in buffering plasma S1P and identify a disturbance in the capacity after transfusion. Changes in S1P content may contribute to an RBC storage lesion. Further studies should investigate the clinical significance of alterations in circulating S1P levels and the potential value of enriching stored RBCs with S1P.

UR - http://www.scopus.com/inward/record.url?scp=80052419055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052419055&partnerID=8YFLogxK

U2 - 10.1042/CS20110236

DO - 10.1042/CS20110236

M3 - Article

VL - 121

SP - 565

EP - 572

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 12

ER -